Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Smith Brad DOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:92Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Feinberg David TOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:51Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Hilzinger Kurt JOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:270Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Renaudin George IIOwnership Type:Indirect OwnershipSecurities:Phantom Stock UnitsNature of Transaction:J - Other transaction# or value acquired/disposed of:8Price:$346.72
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,226Price:$366.11
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:3,566Price:--
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Deshpande SamirOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,302Price:$366.11
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Deshpande SamirOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:3,770Price:--
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Broussard Bruce DOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-8,473Price:$366.11
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Broussard Bruce DOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:22,572Price:--
Filings by filing date
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Smith Brad DOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:92Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Feinberg David TOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:51Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Hilzinger Kurt JOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:270Price:$348.41
-
Mar 28, 2024 (filed on Apr 01, 2024)Insider Name:Renaudin George IIOwnership Type:Indirect OwnershipSecurities:Phantom Stock UnitsNature of Transaction:J - Other transaction# or value acquired/disposed of:8Price:$346.72
-
Feb 21, 2024 (filed on Feb 23, 2024)Insider Name:Rechtin James A.Ownership Type:Direct OwnershipSecurities:OptionsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:15,772Price:--
-
Feb 21, 2024 (filed on Feb 23, 2024)Insider Name:Rechtin James A.Ownership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:4,085Price:--
-
Feb 21, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:OptionsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,389Price:--
-
Feb 21, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,396Price:--
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,226Price:$366.11
-
Feb 22, 2024 (filed on Feb 23, 2024)Insider Name:Fleming William KevinOwnership Type:Direct OwnershipSecurities:Humana CommonNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:3,566Price:--
News
Biz Brief
Sector: Healthcare | Industry: Managed Health Care |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 500 W Main St LOUISVILLE KY 40202 |
Tel: | 1-502-5802652 |
Website: | https://www.humana.com |
IR: | See website |
Key People | ||
James A. Rechtin President, Chief Operating Officer | Vishal Agrawal Chief Strategy and Corporate Development Officer | Bruce D. Broussard Chief Executive Officer, Director |
Susan M. Diamond Chief Financial Officer | David Dintenfass President - Enterprise Growth | George Renaudin President - Medicare and Medicaid |
Sanjay Shetty President - CenterWell | John- Paul W. Felter Senior Vice President, Chief Accounting Officer, Controller | Timothy S. Huval Chief Administrative Officer | Samir M. Deshpande Chief Information Officer |
Business Overview |
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations. |
Financial Overview |
For the fiscal year ended 31 December 2023, Humana Inc revenues increased 15% to $106.37B. Net income decreased 11% to $2.49B. Revenues reflect Insurance segment increase of 15% to $102.27B. Net income was offset by Insurance segment income decrease of 12% to $2.65B. Dividend per share increased from $3.15 to $3.54. Basic Earnings per Share excluding Extraordinary Items decreased from $22.20 to $20.09. |
Employees: | 67,600 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $45,239M as of Dec 31, 2023 |
Annual revenue (TTM): | $106,374M as of Dec 31, 2023 |
EBITDA (TTM): | $5,479M as of Dec 31, 2023 |
Net annual income (TTM): | $2,489M as of Dec 31, 2023 |
Free cash flow (TTM): | $2,546M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $6,962M as of Dec 31, 2023 |
Shares outstanding: | 120,548,748 as of Feb 29, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |